Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 660 is a protein containing multiple C2H2-type zinc finger domains, encoded by the ZNF660 gene located on human chromosome 3[1][5][7]. It is part of a large family of zinc finger proteins that typically function as transcription factors, regulating gene expression by binding sequence-specific double-stranded DNA motifs in the nucleus[1][3][8]. The precise biological roles of ZNF660 remain incompletely characterized, but like other zinc finger proteins, it may contribute to DNA recognition, transcriptional activation, and related gene regulatory functions[2][8]. There are currently no known associated drugs, disease roles, or biomarker applications for clinical use. No information suggests safety concerns or direct therapeutic targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 660 (ZNF660).